Johnson & Johnson (JNJ) Stake Raised by SNS Financial Group LLC
SNS Financial Group LLC increased its stake in Johnson & Johnson (NYSE:JNJ) by 39.5% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 16,093 shares of the company’s stock after buying an additional 4,556 shares during the period. SNS Financial Group LLC’s holdings in Johnson & Johnson were worth $2,004,000 as of its most recent filing with the SEC.
Several other hedge funds also recently modified their holdings of JNJ. Norges Bank acquired a new position in shares of Johnson & Johnson during the fourth quarter worth approximately $3,220,322,000. Fisher Asset Management LLC boosted its position in shares of Johnson & Johnson by 1.2% in the first quarter. Fisher Asset Management LLC now owns 11,093,898 shares of the company’s stock worth $1,381,745,000 after buying an additional 136,764 shares during the last quarter. Sumitomo Mitsui Trust Holdings Inc. boosted its position in shares of Johnson & Johnson by 0.5% in the first quarter. Sumitomo Mitsui Trust Holdings Inc. now owns 7,948,942 shares of the company’s stock worth $990,041,000 after buying an additional 42,144 shares during the last quarter. Macquarie Group Ltd. boosted its position in shares of Johnson & Johnson by 5.6% in the fourth quarter. Macquarie Group Ltd. now owns 6,851,198 shares of the company’s stock worth $789,328,000 after buying an additional 362,616 shares during the last quarter. Finally, Bank of Montreal Can boosted its position in shares of Johnson & Johnson by 0.4% in the first quarter. Bank of Montreal Can now owns 6,837,755 shares of the company’s stock worth $851,642,000 after buying an additional 26,606 shares during the last quarter. Institutional investors and hedge funds own 66.06% of the company’s stock.
Johnson & Johnson (NYSE:JNJ) traded up 0.70% during trading on Wednesday, hitting $133.19. 512,915 shares of the stock were exchanged. Johnson & Johnson has a one year low of $109.32 and a one year high of $137.08. The stock’s 50 day moving average is $133.35 and its 200-day moving average is $125.64. The company has a market cap of $358.79 billion, a price-to-earnings ratio of 22.54 and a beta of 0.78.
Johnson & Johnson (NYSE:JNJ) last issued its quarterly earnings results on Tuesday, July 18th. The company reported $1.83 EPS for the quarter, beating analysts’ consensus estimates of $1.79 by $0.04. The company had revenue of $18.84 billion for the quarter, compared to analyst estimates of $18.94 billion. Johnson & Johnson had a return on equity of 26.76% and a net margin of 22.52%. The company’s quarterly revenue was up 1.9% compared to the same quarter last year. During the same period last year, the company earned $1.74 earnings per share. On average, equities research analysts expect that Johnson & Johnson will post $7.18 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Tuesday, September 12th. Stockholders of record on Tuesday, August 29th will be issued a dividend of $0.84 per share. This represents a $3.36 dividend on an annualized basis and a dividend yield of 2.54%. The ex-dividend date is Friday, August 25th. Johnson & Johnson’s dividend payout ratio (DPR) is 56.76%.
COPYRIGHT VIOLATION WARNING: “Johnson & Johnson (JNJ) Stake Raised by SNS Financial Group LLC” was originally reported by Daily Political and is the sole property of of Daily Political. If you are accessing this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark & copyright legislation. The original version of this piece can be read at https://www.dailypolitical.com/2017/08/09/johnson-johnson-jnj-stake-raised-by-sns-financial-group-llc.html.
JNJ has been the topic of a number of recent research reports. BidaskClub raised shares of Johnson & Johnson from a “buy” rating to a “strong-buy” rating in a report on Saturday, June 17th. Jefferies Group LLC reaffirmed a “hold” rating and issued a $135.00 target price (down from $140.00) on shares of Johnson & Johnson in a report on Sunday, May 14th. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $128.00 target price on shares of Johnson & Johnson in a report on Thursday, June 15th. Atlantic Securities cut shares of Johnson & Johnson from a “neutral” rating to an “underweight” rating and set a $113.00 target price on the stock. in a report on Friday, July 21st. Finally, Barclays PLC reaffirmed an “equal weight” rating and issued a $130.00 target price (up from $125.00) on shares of Johnson & Johnson in a report on Monday, April 17th. Three equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and eleven have given a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $133.72.
In other news, VP Dominic J. Caruso sold 82,591 shares of the firm’s stock in a transaction on Thursday, July 20th. The stock was sold at an average price of $136.72, for a total transaction of $11,291,841.52. Following the transaction, the vice president now directly owns 226,693 shares of the company’s stock, valued at $30,993,466.96. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, VP Paulus Stoffels sold 102,692 shares of the firm’s stock in a transaction on Monday, July 24th. The shares were sold at an average price of $133.14, for a total value of $13,672,412.88. Following the transaction, the vice president now directly owns 230,342 shares in the company, valued at $30,667,733.88. The disclosure for this sale can be found here. 0.19% of the stock is currently owned by company insiders.
About Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being.
Want to see what other hedge funds are holding JNJ? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Johnson & Johnson (NYSE:JNJ).
Receive News & Ratings for Johnson & Johnson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Johnson & Johnson and related companies with MarketBeat.com's FREE daily email newsletter.